Cited by

• Titanium is a potent inducer of contact activation: implications for intravascular devices.

  Litvak M, Shamanaev A, Zalawadiya S, Matafonov A, Kobrin A, Feener EP, Wallisch M, Tucker EI, McCarty OJT, Gailani D. Litvak M, et al. J Thromb Haemost. 2023 May;21(5):1200-1213. doi: 10.1016/j.jtha.2022.12.014. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696212 Free PMC article.
• The analysis of unplanned readmissions after left ventricular assist device implantation as bridge-to-transplant.

  Sezgin M, Rabuş MB, Selçuk E, Altaş Ö, Sarıkaya S, Balkanay M, Kırali MK. Sezgin M, et al. Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):55-62. doi: 10.5606/tgkdc.dergisi.2020.18836. eCollection 2020 Jan. Turk Gogus Kalp Damar Cerrahisi Derg. 2020. PMID: 32175143 Free PMC article.
• Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.

  Karimi A, Beaver TM, Hess PJ, Martin TD, Staples ED, Schofield RS, Hill JA, Aranda JM, Klodell CT. Karimi A, et al. Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):457-65. doi: 10.1093/icvts/ivt546. Epub 2014 Jan 12. Interact Cardiovasc Thorac Surg. 2014. PMID: 24421208 Free PMC article.
• Anticoagulation management in mechanical circulatory support.

  Adatya S, Bennett MK. Adatya S, et al. J Thorac Dis. 2015 Dec;7(12):2129-38. doi: 10.3978/j.issn.2072-1439.2015.10.65. J Thorac Dis. 2015. PMID: 26793333 Free PMC article. Review.
• A stable patient with a left ventricular assist device was admitted to the outpatient clinic with ventricular fibrillation.

  Doğan Ö, Arslan Ş, Özyıldırım S, Abacı O. Doğan Ö, et al. Anatol J Cardiol. 2021 Aug;25(8):595-597. doi: 10.5152/AnatolJCardiol.2021.02009. Anatol J Cardiol. 2021. PMID: 34369890 Free PMC article. No abstract available.